AGP Picks
View all

Today in Healthcare: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Today in Healthcare.

Press releases published on November 19, 2026

Clinical Reference Laboratory Service Market Report Details Key Segments, Regional Developments, and Leading Competitors
Clinical Trial Management System Market Report: Size, Trends, Innovations, and Global Forecast to 2030
The Clinical Trial Investigative Site Network Market Is Expected to Grow Rapidly at an 8.3% CAGR Through 2030
Industry Outlook for Clinical Risk Grouping Solution Market Strengthens as Global Demand Increases
The Clinical Trial Data Visualization Market Is Projected to Grow to $1.82 Billion by 2030, Expanding at a CAGR of 15.4%
The Clinical Trial Imaging Market is Projected to Reach $2.36 Billion by 2030 Driven by Robust Industry Expansion
Arcera Life Sciences and Innogen Pharmaceuticals Sign Exclusive Licensing Agreement to Expand Access to Cardiometabolic Care Across International Markets
Asgard Therapeutics awarded €2.5m EIC Accelerator grant to advance lead program AT-108 toward the clinic
DISCO Pharmaceuticals Announces Strategic Collaboration with AbbVie to Advance Next-Generation AND-Gated Bispecific Therapeutics for Solid Tumors
Scancell Provides Corporate and Clinical Update
AVA6207 Overcomes Topoisomerase I Inhibitor Resistance In Vitro and In Vivo with Robust and Tumor-Selective Release of Dual Exatecan and ATR Inhibitor Payloads
Press Release: Sanofi’s next-generation rabies vaccine, VaxRabeo, approved in the EU for all ages
Communiqué de presse : VaxRabeo, le vaccin contre la rage de nouvelle génération de Sanofi, approuvé dans l’UE pour tous les âges
Fangzhou and Baiyunshan Pharmaceutical Launch AI-Powered Chronic Disease Management Initiative
SELLAS Life Sciences Announces Pricing of $150.0 Million Underwritten Public Offering
The Princeton Review Selects Stetson University for 2027 Mental Health Services Honor Roll
FDA Approves Livsayis™ (cemdisiran) for Adults Living with Generalized Myasthenia Gravis
Immutep Reports Encouraging Disease-Free Survival from EFTISARC-NEO Phase II Trial in Soft Tissue Sarcoma
HUTCHMED Highlights HMPL-A830 Pre-Clinical Data Presented at the 38th EORTC-NCI-AACR International Conference on Molecular Targets and Cancer Therapeutics

Share this page:

Advanced Search Options

Search for:

Search scope:

Type:

Search in:

Date range:

The last

Sort by:

Sign up for:

Today in Healthcare

The daily local news briefing you can trust. Every day. Subscribe now.

By signing up, you agree to our Terms & Conditions.